Novo Nordisk's (NOVOB DC) CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 Trial
Novo Nordisk's latest trial results for CagriSema indicate a significant improvement in HbA1c reduction and weight loss for adults with type 2 diabetes.
Newsquawk Daily Economic Releases - 3rd February 2026
US Ambassador to India says that US President Trump has spoken with India's PM Modi
Novo Nordisk's (NOVOB DC) CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 Trial
US President Trump has built a USD 484mln war chest ahead of the midterm elections, via Campaign finance filing
Oracle (ORCL) is reportedly seeking a USD 5bln in convertible bond issue
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This strong performance could bolster the company's position in the diabetes treatment market, potentially attracting greater investor interest and impacting their stock positively, especially if future guidance reflects these outcomes.
Related headlines
- Novo Nordisk (NOVOB DC) announced first results from the STEP Young phase 3 trial; The trial met its primary endpoint, demonstrating superior body mass index reduction at week 686 days ago
- Stellantis (STLAM IM/STLAP FP) plans to invest EUR 1bln+ to design and build a new van in France1 day ago
- Ipsen (IPN FP) CEO says that they are considering potential US manufacturing investment for plant to make neuroscience drugs2 days ago
- European Movers: Alstom (ALO FP) +1.7%, Airbus (AIR FP) +1.6%, UniCredit (UCG IM) +1%, Commerzbank (CBK GY) +0.6%, SAP (SAP GY) -1.6%2 days ago
- Additional European Equity News - 11th September 20262 days ago
- European Equity pre-Market Summary - 11th September 2026: European bourses rebound, with focus on the US CPI2 days ago
- Newsquawk Daily European Equity Opening News - 11th September 20262 days ago
- Ryanair (RYA ID) CEO says that if oil prices remain higher into the next year, then he believes that there will be a "significant" uplift in airfares; have stopped hedging oil prices in recent weeks3 days ago
- European Movers: Fortum (FORTUM FH) +3%, Porsche AG (P911 GY) +1.4%, Novartis (NOVN SW) +0.8%, Associated British Foods (ABF LN) -10%3 days ago
- Additional European Equity News - 10th September 20263 days ago
- European Equity pre-Market Summary - 10th September 2026: European bourses set for a mildly firmer open; Porsche AG lifts guidance3 days ago
- Newsquawk Daily European Equity Opening News - 10th September 20263 days ago
- Crystler (STLAM IM/STLAP FP) files to recall over 200k US vehicles4 days ago
- European Movers: Airbus (AIR FP) -1.3%, LVMH (MC FP) -1.3%, Orsted (ORSTED DC) -1.6%, Inditex (ITX SM) -3%, Burberry (BRBY LN) -3%4 days ago
- Additional European Equity News - 9th September 20264 days ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results4 days ago
- Newsquawk Daily European Equity Opening News - 9th September 20264 days ago
- European Movers: Airbus (AIR FP) -0.7%, Schneider Electric (SU FP) -0.9%, Société Générale (GLE FP) -1.6%, Infineon (IFX GY) -1.9%, Novartis (NOVN SW) -9%, 5 days ago
- Additional European Equity News - 8th September 20265 days ago
- European Equity pre-Market Summary - 8th September 2026: Novartis does not meet Phase 3 primary endpoint; European equity futures indicative of a slightly lower open, as energy picks up5 days ago
The whole workspace, free to try.
Try it free